References
- The Task Force on Acute Heart Failure of the European Society of Cardiology. Guidelines on the diagnosis and treatment of heart failure. Eur Heart J. 2005;26:384–416.
- Kellum JA, Pinsky MR. Use of vasopressor agents in critically ill patients. Crit Care 2002; 8: 236–41
- Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications. J Am Coll Cardiol. 2005; 46: 57–64
- Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: Description of population. Eur Heart J. 2006; 27: 2725–36
- Tavazzi L, Maggioni A, Lucci D, Cacciatore G, Ansalone G, Oliva F, et al. Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J. 2006; 27: 1207–15
- De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J. 2006; 27: 1908–20
- Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360: 196–202
- Shah MR, Hasselblad V, Stevenson LW, Binanay C, O'Connor CM, Sopko G, et al. Impact of the Pulmonary Artery Catheter in Critically Ill Patients. JAMA 2005; 294: 1664–70
- Gonzalez-Vilchez F, Ayuela J, Ares M, Mata NS, Gonzalez AG, Duran RM, et al. Comparison of Doppler echocardiography, color M-mode Doppler, and Doppler tissue imaging for the estimation of pulmonary capillary wedge pressure. J Am Soc of Echocardiog. 2002; 15: 1245–50